Inha Jo, DO

Assistant Professor , Pediatrics

Inha Jo



  • Kansas City University, DO
  • Indiana State University, MS
  • Purdue University, BS


  • Published on 1/9/2013

    Mani T, Wang F, Knabe WE, Sinn AL, Khanna M, Jo I, Sandusky GE, Sledge GW, Jones DR, Khanna R, Pollok KE, Meroueh SO. Small-molecule inhibition of the uPARĀ·uPA interaction: synthesis, biochemical, cellular, in vivo pharmacokinetics and efficacy studies in breast cancer metastasis. Bioorg Med Chem. 2013 Apr 01; 21(7):2145-55. PMID: 23411397.

    Read at: PubMed
  • Published on 6/12/2012

    Wang F, Eric Knabe W, Li L, Jo I, Mani T, Roehm H, Oh K, Li J, Khanna M, Meroueh SO. Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor. Bioorg Med Chem. 2012 Aug 01; 20(15):4760-73. PMID: 22771232.

    Read at: PubMed
  • Published on 10/4/2011

    Wang F, Li J, Sinn AL, Knabe WE, Khanna M, Jo I, Silver JM, Oh K, Li L, Sandusky GE, Sledge GW, Nakshatri H, Jones DR, Pollok KE, Meroueh SO. Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasis. J Med Chem. 2011 Oct 27; 54(20):7193-205. PMID: 21851064.

    Read at: PubMed
  • Published on 9/29/2011

    Khanna M, Wang F, Jo I, Knabe WE, Wilson SM, Li L, Bum-Erdene K, Li J, W Sledge G, Khanna R, Meroueh SO. Targeting multiple conformations leads to small molecule inhibitors of the uPARĀ·uPA protein-protein interaction that block cancer cell invasion. ACS Chem Biol. 2011 Nov 18; 6(11):1232-43. PMID: 21875078.

    Read at: PubMed
  • Published on 3/25/2011

    Li L, Khanna M, Jo I, Wang F, Ashpole NM, Hudmon A, Meroueh SO. Target-specific support vector machine scoring in structure-based virtual screening: computational validation, in vitro testing in kinases, and effects on lung cancer cell proliferation. J Chem Inf Model. 2011 Apr 25; 51(4):755-9. PMID: 21438548.

    Read at: PubMed
  • Published on 8/12/2010

    Li L, Li J, Khanna M, Jo I, Baird JP, Meroueh SO. Docking Small Molecules to Predicted Off-Targets of the Cancer Drug Erlotinib Leads to Inhibitors of Lung Cancer Cell Proliferation with Suitable In vitro Pharmacokinetic Properties. ACS Med Chem Lett. 2010 Aug 12; 1(5):229-233. PMID: 20824148.

    Read at: PubMed

View all profiles